Since its establishment in 1982, Gilde has invested in more than 250 companies. With offices in The Netherlands, France and Switzerland Gilde is one of the most prominent continental European private equity investors.
Gilde operates through specialized investment funds for buy outs and life sciences. Funds under management exceed â‚¬2 billion.
|Chroma Therapeutics||6/09||Venture Round||$24.5M||6|